Jason Held, PhD

Primary Academic Title

Assistant Professor of Medicine, Division of Oncology, Washington University School of Medicine

Research Interest

Proteomics; Regulation of signal transduction by posttranslational modifications, especially redox regulation of cysteines.

Education

2006: PhD, pharmaceutical sciences and pharmacogenomics, University of California San Francisco

Training

2006 - 2008: Fellow, The Buck Institute for Research on Aging, Novato, Calif.

Selected Research Publications

Epigenetic regulation during cancer transitions across 11 tumour types.

Terekhanova NV, Karpova A, Liang WW, [...] Held JM, [...] Ding L
Nature 2023

Proteins in Tumor-Derived Plasma Extracellular Vesicles Indicate Tumor Origin.

Barlin M, Erdmann-Gilmore P, Mudd JL, [...] Held JM
Mol Cell Proteomics 2023

Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102.

Brashears CB, Prudner BC, Rathore R, [...] Held JM, [...] Van Tine BA
Clin Cancer Res 2022

Automating Assignment, Quantitation, and Biological Annotation of Redox Proteomics Datasets with ProteoSushi.

van der Post S, Seymour RW, Mooradian AD, Held JM
Methods Mol Biol 2022

ProteoSushi: A Software Tool to Biologically Annotate and Quantify Modification-Specific, Peptide-Centric Proteomics Data Sets.

Seymour RW, van der Post S, Mooradian AD, Held JM
J Proteome Res 2021

View All Publications